Perspective Stories
Will Bank of Hawaii (USA Stocks:BOH) and First Hawaiian (USA Stocks:FHB) deliver in February?
six days ago at Macroaxis By Rifka Kats |
Considering First Hawaiian's (FHB) solid financial footing with a net income from continuing operations of 267.1M and a book value of 20.71, investors might find it appealing to buy, especially if the stock price dips below its 200-day moving average of 23.57.
Important Highlights
To assess the impact of market fluctuations on First Hawaiian and Bank, you can examine their technical indicators. This comparison can help determine if combining these stocks in your portfolio might reduce overall market risk. Additionally, you might explore pair trading by going long on Bank and short on First Hawaiian. Continue Reading...- FHB First Hawaiian
- Latest First Hawaiian Bank Cuts Stake in NVIDIA Co. - MarketBeat
- FHB 27.62 0.83
- Low 26.73
- High 27.91
- Volume 2.2 M
- Alpha 0.17
- Beta 0.14
- Return On Equity 0.0901
- Return On Asset 0.0093
- Profit Margin 0.28 %
- Operating Margin 0.39 %
- Current Valuation 2.6 B
- Shares Outstanding 127.89 M
- Shares Owned By Insiders 0.57 %
- Shares Owned By Institutions 99.43 %
- Number Of Shares Shorted 4.7 M
- Price To Earning 16.64 X
- Price To Book 1.29 X
- Price To Sales 4.23 X
- Revenue 1.13 B
- Gross Profit 809.72 M
- EBITDA (24.18 M)
- Net Income 234.98 M
- Cash And Equivalents 1.54 B
- Cash Per Share 12.09 X
- Total Debt 500 M
- Debt To Equity 6.07 %
- Book Value Per Share 20.71 X
- Cash Flow From Operations 255.03 M
- Short Ratio 5.38 X
- Earnings Per Share 1.75 X
- Price To Earnings To Growth 3.05 X
- Target Price 26.5
- Number Of Employees 2.02 K
- Beta 0.95
- Market Capitalization 3.43 B
- Total Asset 24.93 B
- Retained Earnings 837.86 M
- Annual Yield 0.04 %
- Five Year Return 4.00 %
- Net Asset 24.93 B
- Last Dividend Paid 1.04
- Accumulation Distribution 91426.62
- Daily Balance Of Power 0.7034
- Rate Of Daily Change 1.03
- Day Median Price 27.32
- Day Typical Price 27.42
- Price Action Indicator 0.72
- Period Momentum Indicator 0.83
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
By examining the technical and fundamental indicators of Wells Fargo and another bank, you can assess how market fluctuations impact their stock prices. This analysis can help determine if combining these stocks in your portfolio might reduce overall market risk. Additionally, you might consider a pair trading strategy, where you take a long position in the other bank and a short position in Wells Fargo.
over two weeks ago at Macroaxis By Ellen Johnson |
Knowledge is power, and investing in Educational Development Corp. might just empower your portfolio. As a player in the publishing industry, this NASDAQ-listed company offers a compelling opportunity with its solid financial footing. With a market capitalization of $14.6M and a book value per share of 4.96, the stock is trading at a level that suggests potential undervaluation.
over two weeks ago at Macroaxis By Gabriel Shpitalnik |
Accolade, a player in the healthcare sector, presents a compelling investment opportunity right now. Despite a challenging financial landscape, with an operating income loss of 114.5M and a high probability of bankruptcy at 95.30%, the company's strong current ratio of 3.33X indicates robust liquidity, suggesting it can meet its short-term obligations comfortably. Trading on NASDAQ, Accolade's market capitalization stands at 277M, with a price-to-sales ratio of just 0.63X, making it attractively valued compared to its peers.
over three weeks ago at Macroaxis By Gabriel Shpitalnik |
When it comes to investing, knowledge is power. AIM ImmunoTech Inc., a player in the biotechnology sector, is making waves with its focus on developing treatments for cancer, viral diseases, and immune-deficiency disorders. With a market capitalization of $12.6 million and a lead product candidate, Ampligen, aimed at chronic fatigue syndrome, AIM ImmunoTech presents a unique investment opportunity.
over three weeks ago at Macroaxis By Vlad Skutelnik |
All that glitters is not gold, and this seems particularly true for My Size (MYSZ) as it struggles to maintain investor interest amid rising competition from Powerbridge (PBTS). With a staggering operating loss of 5.4 million and a probability of bankruptcy looming at over 95%, My Size's financial health raises red flags for potential investors. As the company navigates the turbulent waters of the software application industry, the question remains whether it can regain its footing or if Powerbridge will continue to capture the spotlight. Some millennials might not be particularly interested in the software sector, but let's take a closer look at how My Size's fundamentals stack up against Powerbridge Technologies. We'll explore the competitive elements of both MYSZ and Powerbridge to see how they compare.
over a month ago at Macroaxis By Nico Santiago |
As investors search for promising opportunities in the dynamic landscape of advertising agencies, Direct Digital Holdings has emerged as a potential contender worth considering. With a total revenue of $157.1 million and a gross profit of $28 million, the company demonstrates a solid financial foundation in the entertainment service category. Despite its relatively small workforce of 90 employees, Direct Digital Holdings has managed to carve out a niche in the industry, showcasing resilience and adaptability.
over a month ago at Macroaxis By Gabriel Shpitalnik |
To compare how market fluctuations impact GEE Group and Hudson, you can look at basic indicators for both companies. This analysis can help determine if combining them in a portfolio might reduce market risk. Additionally, you might consider a pair trading strategy, where you take a long position in Hudson and a short position in GEE.
over a month ago at Macroaxis By Aina Ster |
Unusual Machines, trading under the ticker UMAC on the NYSE MKT, is an intriguing player in the shell companies sector. With a current valuation of $12.71 million and a net income from continuing operations showing a loss of $2.4 million, potential investors might find themselves weighing the risks against the opportunities. The company's enterprise value stands at $12.7 million, indicating a relatively small market presence.
over two months ago at Macroaxis By Nico Santiago |
By examining key indicators for Academy Sports and Williams, you can assess how market fluctuations impact their stock prices. This analysis can help determine if combining these stocks in a portfolio might reduce overall market risk. Additionally, you might consider a pair trading strategy, where you take a long position in Williams and a short position in Academy Sports.
over two months ago at Macroaxis By Vlad Skutelnik |